Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Tumor Lysis Syndrome 4Lymphoma 4Leukemia 4Hyperuricemia 4Neoplasms 2Recurrence 1Nutritional and Metabolic Diseases 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Hematologic Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 56fludarabine phosphate 30Filgrastim 28Peripheral Blood Stem Cell Transplantation 27Radiotherapy 26Cyclosporine 23Busulfan 23Etoposide 21Mycophenolic Acid 20Whole-Body Irradiation 19Antilymphocyte Serum 19Methotrexate 17Methylprednisolone 15Melphalan 14Cytarabine 13Vincristine 11Tacrolimus 11Thiotepa 10Prednisone 10Cord Blood Stem Cell Transplantation 10Rituximab 9Doxorubicin 9Leucovorin 7aldesleukin 6Granulocyte Colony-Stimulating Factor 6sargramostim 5Psychiatric Rehabilitation 5Carboplatin 5Therapeutics 4Daunorubicin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Dendritic Cell Sarcoma, Interdigitating × Urate Oxidase × Clear all
NCT00057811 2014-09-19

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Children's Oncology Group

Phase 2 Completed
97 enrolled 13 charts
LymphoidSarcoma

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡